SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-153697
Filing Date
2018-05-07
Accepted
2018-05-07 09:04:01
Documents
1
Effectiveness Date
2018-05-07

Document Format Files

Seq Description Document Type Size
1 8-K d579603d8k.htm DEFA14A 13873
  Complete submission text file 0001193125-18-153697.txt   14966
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEFA14A | Act: 34 | File No.: 001-37695 | Film No.: 18809816
SIC: 2834 Pharmaceutical Preparations